Year All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2012 2011 Nov 10, 2026 Ardelyx to Participate at the Jefferies Global Healthcare Conference in London Nov 3, 2026 Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update Nov 3, 2026 Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation Oct 23, 2026 Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders Oct 20, 2026 Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 Oct 12, 2026 Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C Oct 5, 2026 Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026 Sep 30, 2026 Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards Sep 1, 2026 Ardelyx to Participate in Upcoming Investor Conferences Aug 6, 2026 Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update